SECTOR : Biotech
ENTRY DATE : 2017
BUSINESS : Venture Capital
WEB : www.octimet.com/

Octimet Oncology

Development of MET kinase inhibitors for cancer treatment

Octimet Oncology is a Belgian company developing highly selective, differentiated MET kinase inhibitors for the treatment of solid cancers.